Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07202091) titled 'Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Monash University
Condition:
Myeloma
Leukemia
Non Hodgkin'
s Lymphoma
Intervention:
Drug: Trimethoprim Sulfamethoxazole
Drug: Amoxycillin/clavulanic acid
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: May 6, 2025
Target Sample Size: 900
Countries of Recruitme...